Quest Diagnostics Named One of Fortune's Most Admired Companies for Twelfth Year Running

Quest Diagnostics Achieves Esteemed Recognition for Commitment to Healthcare Excellence

Quest Diagnostics, a leader in diagnostic information services, earns a prestigious spot on Fortune magazine's 2026 World's Most Admired Companies™ list for the twelfth consecutive year. This recognition highlights the unwavering dedication of the company's 55,000 employees to its mission of fostering a healthier world, as articulated by CEO Jim Davis. Quest Diagnostics attains a remarkable second place in the "Health Care: Pharmacy and Other Services" category, a testament to its robust reputation built on nine essential attributes, including innovation, product quality, and social responsibility. The evaluation, conducted in partnership with Korn Ferry, involves a comprehensive survey of thousands of executives, directors, and analysts, assessing nearly 700 companies to identify those that stand out in their respective industries.

The ranking reflects Quest Diagnostics' pivotal role in the healthcare ecosystem, where it provides vital diagnostic insights that empower patients, physicians, and healthcare organizations to enhance health outcomes. With access to one of the largest databases of de-identified clinical lab results, the company plays a significant part in the identification and treatment of various diseases. By facilitating actionable insights from laboratory testing, Quest Diagnostics not only supports clinical decision-making but also encourages healthier behaviors and better healthcare management across the nation. Serving approximately one in three adult Americans and half of the healthcare providers in the U.S., Quest's contributions are integral to improving public health.

This accolade serves as both a recognition of Quest Diagnostics' esteemed standing within the healthcare industry and a reaffirmation of its commitment to delivering high-quality healthcare solutions. The company’s focus on innovation and social responsibility resonates well with industry stakeholders, further solidifying its reputation as a trusted partner in the pursuit of improved health outcomes. As healthcare continues to evolve, Quest Diagnostics remains dedicated to transforming lives through its comprehensive diagnostic services.

In addition to its recognition by Fortune, Quest Diagnostics actively engages in initiatives aimed at enhancing patient care and advancing public health. The company’s efforts in promoting preventive healthcare measures and utilizing data analytics to drive better health decisions exemplify its commitment to innovation in the healthcare sector. As it continues to lead in diagnostic services, Quest Diagnostics remains poised to make significant contributions to the overall improvement of health outcomes in the communities it serves.